An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs)—a type of ...

An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...

Experts at the 20th Annual Diabetes Conference say new medications are improving treatment, but diabetes and obesity continue ...

Discover how a common diabetes medication, metformin, could significantly reduce the risk of age-related macular degeneration ...

Millions of people with type 2 diabetes who take semaglutide, the active ingredient in Ozempic and Wegovy, can draw some ...

A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...

As obesity rates climb to nearly 45% among Filipino adults,Novo Nordisk country head is pushing advocacy to change how the ...

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...

A new report states that older adults using GLP-1 drugs may have a higher risk of loss of muscle mass, malnutrition, ...

A half-mile section of Washington Heights has been transformed into an open-air prescription drug bazaar, with brazen vendors ...

A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare ...

Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults ...